Savant Capital’s ResMed RMD Stock Holding History

Savant Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Buy	4,624 +411	+10%	+$102K	0.01%	620
2025 Q4	$1.01M	Sell	4,213 -122	-3%	-$31.2K	0.01%	576
2025 Q3	$1.19M	Sell	4,335 -9	-0.2%	-$2.46K	0.01%	518
2025 Q2	$1.12M	Buy	4,344 +473	+12%	+$113K	0.01%	488
2025 Q1	$867K	Sell	3,871 -6,925	-64%	-$1.62M	0.01%	517
2024 Q4	$2.47M	Buy	10,796 +487	+5%	+$117K	0.02%	388
2024 Q3	$2.52M	Buy	10,309 +7,501	+267%	+$1.68M	0.02%	360
2024 Q2	$538K	Sell	2,808 -6,271	-69%	-$1.27M	0.01%	771
2024 Q1	$1.8M	Buy	9,079 +5,827	+179%	+$1.07M	0.02%	385
2023 Q4	$559K	Sell	3,252 -372	-10%	-$57.2K	0.01%	539
2023 Q3	$536K	Buy	3,624 +17	+0.5%	+$3.07K	0.01%	508
2023 Q2	$788K	Buy	3,607 +2,649	+277%	+$590K	0.01%	425
2023 Q1	$210K	Buy	+958	New	+$208K	﹤0.01%	676

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Savant Capital's RMD Position: Q1 2026 in Review

Savant Capital increased its ResMed (RMD) stake by 9.8% in Q1 2026, buying an estimated $102K and bringing the position to 4,624 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #620.

Savant Capital first reported a position in RMD in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.52M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Savant Capital held 4,624 shares of ResMed worth $1.04M as of Q1 2026.
Savant Capital bought 411 ResMed shares in Q1 2026, an estimated $102K.
ResMed made up 0.01% of Savant Capital's portfolio in Q1 2026, its #620 holding.
Savant Capital first reported a position in ResMed in Q1 2023 and has held it in 13 quarters since.
Savant Capital's ResMed position peaked at $2.52M in Q3 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.